Carboplatin-based neoadjuvant treatment with peripheral blood stem cell and growth factor support in locally advanced cervical cancer patients with bulky metastatic lymph nodes

Eur J Obstet Gynecol Reprod Biol. 2007 Apr;131(2):236-8. doi: 10.1016/j.ejogrb.2006.04.005. Epub 2006 May 2.

Authors

Gabriella Ferrandina, Alessandro Perillo, Mariagrazia Distefano, Giuseppe D'Agostino, Valerio Gallotta, Luca Pierelli, Giovanni Scambia

PMID: 16650519
DOI: 10.1016/j.ejogrb.2006.04.005

No abstract available

Publication types

Clinical Trial
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adenocarcinoma / blood
Adenocarcinoma / drug therapy*
Adenocarcinoma / pathology
Adult
Antineoplastic Agents / therapeutic use*
Carboplatin / therapeutic use*
Disease Progression
Female
Granulocyte Colony-Stimulating Factor / therapeutic use
Humans
Lymphatic Metastasis
Middle Aged
Neoadjuvant Therapy
Neoplasms, Squamous Cell / blood
Neoplasms, Squamous Cell / drug therapy*
Neoplasms, Squamous Cell / pathology
Peripheral Blood Stem Cell Transplantation*
Treatment Outcome
Uterine Cervical Neoplasms / blood
Uterine Cervical Neoplasms / drug therapy*
Uterine Cervical Neoplasms / pathology

Substances

Antineoplastic Agents
Granulocyte Colony-Stimulating Factor
Carboplatin